This study provides evidence that the newly developed potent small molecule, ASR490, explicitly suppresses Notch1 expression in BCSCs and BC by inhibiting cell proliferation and tumor growth in both in vitro and in vivo models. Here, NOTCH1 is linked to breast cancer.